Allegis Investment Advisors LLC bought a new stake in shares of National Health Investors, Inc. (NYSE:NHI) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 2,731 shares of the real estate investment trust’s stock, valued at approximately $216,000.

Several other institutional investors have also added to or reduced their stakes in NHI. US Bancorp DE boosted its position in National Health Investors by 0.5% in the second quarter. US Bancorp DE now owns 8,836 shares of the real estate investment trust’s stock valued at $700,000 after buying an additional 44 shares during the period. Daiwa Securities Group Inc. boosted its position in National Health Investors by 1.7% in the first quarter. Daiwa Securities Group Inc. now owns 3,200 shares of the real estate investment trust’s stock valued at $232,000 after buying an additional 55 shares during the period. Teacher Retirement System of Texas boosted its position in National Health Investors by 2.0% in the second quarter. Teacher Retirement System of Texas now owns 3,192 shares of the real estate investment trust’s stock valued at $253,000 after buying an additional 62 shares during the period. Family Legacy Inc. boosted its position in National Health Investors by 0.4% in the second quarter. Family Legacy Inc. now owns 17,115 shares of the real estate investment trust’s stock valued at $1,355,000 after buying an additional 65 shares during the period. Finally, Janney Montgomery Scott LLC boosted its position in National Health Investors by 0.7% in the first quarter. Janney Montgomery Scott LLC now owns 11,120 shares of the real estate investment trust’s stock valued at $808,000 after buying an additional 74 shares during the period. Institutional investors own 69.10% of the company’s stock.

National Health Investors, Inc. (NYSE:NHI) opened at 79.12 on Friday. The company’s 50-day moving average price is $77.29 and its 200 day moving average price is $75.13. National Health Investors, Inc. has a 52 week low of $66.31 and a 52 week high of $82.53. The company has a market capitalization of $3.24 billion, a PE ratio of 20.32 and a beta of 0.56.

National Health Investors (NYSE:NHI) last released its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.29 by $0.36. The firm had revenue of $69.84 million for the quarter, compared to the consensus estimate of $67.68 million. National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The business’s revenue for the quarter was up 14.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.22 earnings per share. On average, equities research analysts anticipate that National Health Investors, Inc. will post $3.88 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 10th. Stockholders of record on Friday, September 29th will be given a dividend of $0.95 per share. This represents a $3.80 dividend on an annualized basis and a dividend yield of 4.80%. The ex-dividend date is Thursday, September 28th. National Health Investors’s dividend payout ratio is presently 97.69%.

COPYRIGHT VIOLATION WARNING: “Allegis Investment Advisors LLC Buys New Stake in National Health Investors, Inc. (NHI)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright & trademark law. The original version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/08/18/allegis-investment-advisors-llc-buys-new-stake-in-national-health-investors-inc-nhi.html.

Several brokerages recently issued reports on NHI. BidaskClub upgraded National Health Investors from a “sell” rating to a “hold” rating in a research note on Thursday. Mizuho restated a “neutral” rating on shares of National Health Investors in a research note on Wednesday, June 28th. Zacks Investment Research upgraded National Health Investors from a “sell” rating to a “hold” rating in a research note on Wednesday, August 9th. Stifel Nicolaus raised their price objective on National Health Investors from $80.00 to $82.00 and gave the stock a “buy” rating in a research note on Wednesday, June 21st. Finally, ValuEngine cut National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, June 13th. One research analyst has rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $79.60.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI).

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Stock Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related stocks with our FREE daily email newsletter.